Weber Christian, Fraemohs Line, Dejana Elisabetta
Institute for Molecular Cardiovascular Research, RWTH University Hospital, 52074 Aachen, Germany.
Nat Rev Immunol. 2007 Jun;7(6):467-77. doi: 10.1038/nri2096.
Junctional adhesion molecules (JAMs) of the immunoglobulin superfamily are important in the control of vascular permeability and leukocyte transmigration across endothelial-cell surfaces, by engaging in homophilic, heterophilic and lateral interactions. Through their localization on the endothelial-cell surface and expression by platelets, JAMs contribute to adhesive interactions with circulating leukocytes and platelets. Antibody-blocking studies and studies using genetically modified mice have implicated these functions of JAMs in the regulation of leukocyte recruitment to sites of inflammation and ischaemia-reperfusion injury, in growth-factor-mediated angiogenesis, atherogenesis and neointima formation. The comparison of different JAM-family members and animal models, however, shows that the picture remains rather complex. This Review summarizes recent progress and future directions in understanding the role of JAMs as 'gate keepers' in inflammation and vascular pathology.
免疫球蛋白超家族的连接黏附分子(JAMs)通过参与同嗜性、异嗜性和侧向相互作用,在控制血管通透性以及白细胞跨内皮细胞表面迁移方面发挥重要作用。通过定位于内皮细胞表面并由血小板表达,JAMs有助于与循环中的白细胞和血小板发生黏附相互作用。抗体阻断研究以及使用基因修饰小鼠的研究表明,JAMs的这些功能参与了白细胞募集至炎症和缺血-再灌注损伤部位的调控过程、生长因子介导的血管生成、动脉粥样硬化形成以及新生内膜形成。然而,对不同JAM家族成员和动物模型的比较显示,情况仍然相当复杂。本综述总结了在理解JAMs作为炎症和血管病理中的“守门人”所起作用方面的最新进展和未来方向。